MetLife Investment Advisors »

Mersana Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $64k 34k 1.89
2024-06-30 $132k 66k 2.01
2023-12-31 $108k 47k 2.32
2023-09-30 $59k 47k 1.27
2023-06-30 $154k 47k 3.29
2023-03-31 $192k 47k 4.11
2022-12-31 $273k 47k 5.86
2022-09-30 $315k 47k 6.76
2022-06-30 $178k 39k 4.62
2022-03-31 $100k 25k 3.99
2021-12-31 $168k 27k 6.22
2021-09-30 $164k 17k 9.43
2021-06-30 $351k 26k 13.58
2021-03-31 $342k 21k 16.18
2020-12-31 $610k 23k 26.61
2020-09-30 $427k 23k 18.62
2020-06-30 $486k 21k 23.39
2020-03-31 $107k 18k 5.83